Cytosorbents
CTSO
#10672
Rank
S$26.89 M
Marketcap
S$0.43
Share price
-1.41%
Change (1 day)
-64.11%
Change (1 year)

Earnings for Cytosorbents (CTSO)

Earnings in 2026 (TTM): -S$15.78 Million

According to Cytosorbents's latest financial reports the company's current earnings are S$37.2 Million. In 2025 the company made an earning of -S$10.97 Million, an increase over its 2024 earnings that were of -S$28.99 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Cytosorbents from 2006 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -S$15.78 Million43.87%
2025 -S$10.97 Million-62.16%
2024 -S$28.99 Million-22.49%
2023 -S$37.4 Million-13.52%
2022 -S$43.24 Million34.04%
2021 -S$32.26 Million182.17%
2020 -S$11.44 Million-55.97%
2019 -S$25.97 Million14.17%
2018 -S$22.74 Million95.14%
2017 -S$11.66 Million-22.32%
2016 -S$15.01 Million39.1%
2015 -S$10.79 Million-12.89%
2014 -S$12.38 Million89%
2013 -S$6.55 Million26.65%
2012 -S$5.18 Million-26.02%
2011 -S$7 Million-288.45%
2010 S$3.7 M-4.17%
2009 S$3.87 M-287.19%
2008 -S$2.07 Million-47.12%
2007 -S$3.92 Million41.78%
2006 -S$2.76 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Boston Scientific
BSX
S$4.77 B-30,646.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Hologic
HOLX
S$0.99 B-6,447.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Meridian Bioscience
VIVO.defunct
S$70.78 M-553.11%๐Ÿ‡บ๐Ÿ‡ธ USA